pharma · Fertility · INTI
Inhibitor Therapeutics
INHIBITOR Therapeutics is a pharma organization headquartered in Tampa, USA. It trades on NYSE under ticker INTI. Primary therapeutic focus areas include Fertility. NovaPharmaNews links 2 clinical program(s), 0 drug prof
Tampa, USA HQ
2013 Founded
5 Employees
Public company Type
INTI · NYSE Ticker
Company details
- Status
- Public
- HQ
- Tampa, USA
- Founded
- 2013
- Employees
- 5
- Programs
- 2
- Drugs
- 2
- Patents
- 5
Small RNA sequencing
Phase 1 · gene therapy · Fertility
Small RNA sequencing for Fertility is a Phase 1 program (gene_therapy) at Inhibitor Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code CS2-22033
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Inhibitor Therapeutics
- Phase
- Phase 1
- Modality
- gene_therapy
- Indication
- Fertility
- Status
- completed
- Trials
- 1